Induction of metalloproteinase (MMP1) expression by epidermal growth factor (EGF) receptor stimulation and serum deprivation in human breast tumour cells

European Journal of Cancer Part A

Volumn 32, Issue 12, 1996, Pages 2127-2135

  Nutt, J E ^a   Lunec, J ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

cycloheximide; growth factors; MCF7; MDA MB 231; metalloproteinase; phorbol ester; serum deprivation; T47D

Indexed keywords

COLLAGENASE; CYCLOHEXIMIDE; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; PHORBOL ESTER; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

BLOTTING, NORTHERN; BREAST NEOPLASMS; COLLAGENASES; CULTURE MEDIA, SERUM-FREE; CYCLOHEXIMIDE; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOBLOTTING; MATRIX METALLOPROTEINASE 1; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; RNA, NEOPLASM; TETRADECANOYLPHORBOL ACETATE; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR CELLS, CULTURED;

EID: 0030298455     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00261-4     Document Type: Article

References (30)

1. 1. Sainsbury JRC, Farndon JR, Needham GK, Malcolm AJ, Harris AL. Epidermal growth factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1987, i, 1398-1402.
2. 2. Rios MA, Macias A, Perez R, Lage A, Skoog L. Receptors for epidermal growth factor and estrogen as predictors of relapse in patients with mammary carcinoma. Anticancer Res 1988, 8, 173-176.
3. 3. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991, 64, 327-336.
4. 4. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genetics 1990, 6, 121-125.
5. 5. Shima I, Sasaguri Y, Kusukawa J, et al. Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor. Br J Cancer 1993, 67, 721-727.
6. 6. Davies B, Miles DW, Happerfield LC, et al. Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 1993, 67, 1126-1131.
7. 7. Davies B, Waxman J, Wasan H, et al. Levels of matrix metalloproteinases in bladder cancer correlate with tumour grade and invasion. Cancer Res 1993, 53, 5365-5369.
8. 8. Naylor MS, Stamp GW, Davies BD, Balkwill FR. Expression and activity of MMPS and their regulators in ovarian cancer. Int J Cancer 1994, 58, 50-56.
9. 9. Sato H, Kida Y, Mai M, et al. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 1992, 7, 77-83.
10. 10. Urbanski SJ, Edwards DR, Maitland A, Leco KJ, Watson A, Kossakowska AE. Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer 1992, 66, 1188-1194.
11. 11. Otani Y, Okazaki I, Arai M, et al. Gene expression of interstitial collagenase (matrix metalloproteinase 1) in gastrointestinal tract cancers. J Gastroenterol 1994, 29, 391-397.
12. 12. Wolf C, Rouyer N, Lutz Y, et al. Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA 1993, 90, 1843-1847.
13. 13. Polette M, Clavel C, Cockett M, De Bentzmann SG, Murphy G, Birembaut P. Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast pathology. Invasion Metastasis 1993, 13, 31-37.
14. 14. Angel P, Bowmen I, Stein B, Delius H, Rahmsdorf HJ, Herrlich P. 12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5′-flanking region. Mol Cell Biol 1987, 7, 2256-2266.
15. 15. Edwards DR, Murphy G, Reynolds JJ, et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987, 6, 1899-1904.
16. 16. Davidson NE, Gelmann EP, Lippman ME, Dickson RB. Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol Endocrinol 1987, 1, 216-223.
17. 17. Nutt JE, Harris AL, Lunec J. Phorbol ester and bryostatin effects on growth and the expression of oestrogen responsive and TGF-β1 genes in breast tumour cells. Br J Cancer 1991, 64, 671-676.
18. 18. Feinberg AP, Vogelstein B. A technique for radiolabelling restriction endonuclease fragments to high specific activity. Analyt Biochem 1983, 132, 6-13.
19. 19. Ullrich A, Coussens L, Hayflick JS, et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 1984, 309, 418-425.
20. 20. Clifford SC, Thomas DJ, Neal DE, Lunec J. Increased mdr1 gene transcript levels in high-grade carcinoma of the bladder determined by quantitative PCR-based assay. Br J Cancer 1994, 69, 680-686.
21. 21. Thompson EW, Paik S, Brunner N, et al. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cells lines. J Cell Physiol 1992, 150, 534-544.
22. 22. Yoshida K, Tsujino T, Yasui W, et al. Induction of growth factor-receptor and metalloproteinase genes by epidermal growth factor and/or transforming growth factor-α in human gastric carcinoma cell line MKN-28. Jpn J Cancer Res 1990, 81, 793-798.
23. 23. Delany AM, Brinckerhoff CE. Post-transcriptional regulation of collagenase and stromelysin gene expression by epidermal growth factor and dexamethasone in cultured human fibroblasts. J Cell Biochem 1992, 50, 400-410.
24. 24. Yee C, Shiu RPC. Degradation of endothelial basement membrane by human breast cancer cell lines. Cancer Res 1986, 46, 1835-1839.
25. 25. Kao RT, Stern R. Collagenases in human breast carcinoma cell lines. Cancer Res 1986, 46, 1349-1354.
26. 26. Hebert L, Pandey S, Wang E. Commitment to cell death is signaled by the appearance of a terminin protein of 30 kDa. Exp Cell Res 1994, 210, 10-18.
27. 27. Oberhammer F, Wilson JW, Dive C, et al. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 1993, 12, 3679-3684.
28. 28. Galli G, Fratelli M. Activation of apoptosis by serum deprivation in a teratocarcinoma cell line: inhibition by L-acetyl-carnitine. Exp Cell Res 1993, 204, 54-60.
29. 29. Evan GI, Wyllie AH, Gilbert CS, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992, 69, 119-128.
30. 30. Mackay AR, Ballin M, Pelina MD, et al. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion & Metastasis 1992, 12, 168-184.